Osteogenic Potential of Pre-Osteoblastic Cells on a Chitosan-graft-Polycaprolactone Copolymer
- PMID: 29587410
- PMCID: PMC5951336
- DOI: 10.3390/ma11040490
Osteogenic Potential of Pre-Osteoblastic Cells on a Chitosan-graft-Polycaprolactone Copolymer
Abstract
A chitosan-graft-polycaprolactone (CS-g-PCL) copolymer synthesized via a multi-step process was evaluated as a potential biomaterial for the adhesion and growth of MC3T3-E1 pre-osteoblastic cells. A strong adhesion of the MC3T3-E1 cells with a characteristic spindle-shaped morphology was observed from the first days of cell culture onto the copolymer surfaces. The viability and proliferation of the cells on the CS-g-PCL surfaces, after 3 and 7 days in culture, were significantly higher compared to the cells cultured on the tissue culture treated polystyrene (TCPS) control. The osteogenic potential of the pre-osteoblastic cells cultured on CS-g-PCL surfaces was evaluated by determining various osteogenic differentiation markers and was compared to the TCPS control surface. Specifically, alkaline phosphatase activity levels show significantly higher values at both time points compared to TCPS, while secreted collagen into the extracellular matrix was found to be higher on day 7. Calcium biomineralization deposited into the matrix is significantly higher for the CS-g-PCL copolymer after 14 days in culture, while the levels of intracellular osteopontin were significantly higher on the CS-g-PCL surfaces compared to TCPS. The enhanced osteogenic response of the MC3T3-E1 pre-osteoblasts cultured on CS-g-PCL reveals that the copolymer underpins the cell functions towards bone tissue formation and is thus an attractive candidate for use in bone tissue engineering.
Keywords: biomaterial; bone tissue engineering; chitosan; osteogenic potential; polycaprolactone; pre-osteoblastic cells.
Conflict of interest statement
The authors declare no conflict of interest.
Figures







Similar articles
-
Osteoblastic phenotype expression of MC3T3-E1 cultured on electrospun polycaprolactone fiber mats filled with hydroxyapatite nanoparticles.Biomacromolecules. 2007 Aug;8(8):2602-10. doi: 10.1021/bm700451p. Epub 2007 Jul 27. Biomacromolecules. 2007. PMID: 17655356
-
Improvement of dual-leached polycaprolactone porous scaffolds by incorporating with hydroxyapatite for bone tissue regeneration.J Biomater Sci Polym Ed. 2014;25(17):1986-2008. doi: 10.1080/09205063.2014.966800. Epub 2014 Oct 7. J Biomater Sci Polym Ed. 2014. PMID: 25291106
-
Chitosan/gelatin scaffolds support bone regeneration.J Mater Sci Mater Med. 2018 May 5;29(5):59. doi: 10.1007/s10856-018-6064-2. J Mater Sci Mater Med. 2018. PMID: 29730855
-
Osteoblastic phenotype expression of MC3T3-E1 cells cultured on polymer surfaces.Plast Reconstr Surg. 2005 Aug;116(2):567-76. doi: 10.1097/01.prs.0000172986.68749.2d. Plast Reconstr Surg. 2005. PMID: 16079693
-
Biodegradable Chitosan-graft-Poly(l-lactide) Copolymers For Bone Tissue Engineering.Polymers (Basel). 2020 Feb 4;12(2):316. doi: 10.3390/polym12020316. Polymers (Basel). 2020. PMID: 32033024 Free PMC article.
Cited by
-
Preparation and evaluation of a polycaprolactone/chitosan/propolis fibrous nanocomposite scaffold as a tissue engineering skin substitute.Bioimpacts. 2023;13(4):275-287. doi: 10.34172/bi.2023.26317. Epub 2023 Jun 11. Bioimpacts. 2023. PMID: 37645024 Free PMC article.
-
Cell Instructive Behavior of Composite Scaffolds in a Co-Culture of Human Mesenchymal Stem Cells and Peripheral Blood Mononuclear Cells.J Funct Biomater. 2024 Apr 27;15(5):116. doi: 10.3390/jfb15050116. J Funct Biomater. 2024. PMID: 38786628 Free PMC article.
-
Progress in the Development of Chitosan-Based Biomaterials for Tissue Engineering and Regenerative Medicine.Biomolecules. 2019 Sep 10;9(9):470. doi: 10.3390/biom9090470. Biomolecules. 2019. PMID: 31509976 Free PMC article. Review.
-
Chitosan and chito-oligosaccharide: a versatile biopolymer with endless grafting possibilities for multifarious applications.Front Bioeng Biotechnol. 2023 May 19;11:1190879. doi: 10.3389/fbioe.2023.1190879. eCollection 2023. Front Bioeng Biotechnol. 2023. PMID: 37274159 Free PMC article. Review.
-
Biomaterial-Based Nanocomposite for Osteogenic Repurposing of Doxycycline.Int J Nanomedicine. 2021 Feb 12;16:1103-1126. doi: 10.2147/IJN.S298297. eCollection 2021. Int J Nanomedicine. 2021. PMID: 33603371 Free PMC article.
References
-
- Stevens M.M. Biomaterials for bone tissue engineering. Mater. Today. 2008;11:18–25. doi: 10.1016/S1369-7021(08)70086-5. - DOI
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials